Shelby Wright, APRN
Family · Stillwater, OKNPI 1821525718
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Organogenesis Inc. accounts for 94.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $9,118 and has fallen 81.7% since, to $1,669 in 2025. Among family clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 129 payments — averaging $133.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$16K
- Smith+Nephew$591
- Paratek Pharmaceuticals, Inc.$145
- Melinta Therapeutics, LLC$62
- Medline Industries LP$59
- Solventum Corporation$48
- plus $129 from 6 others
What the payments were for
- Consulting fees$8,10047%
- Speaking & faculty fees$6,44037%
- Travel & lodging$3692%
- Food & beverage$2,34114%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 68 | $16,217 |
| Smith+Nephew | 37 | $591 |
| Paratek Pharmaceuticals, Inc. | 9 | $145 |
| Melinta Therapeutics, LLC | 3 | $62 |
| Medline Industries LP | 4 | $59 |
| Solventum Corporation | 2 | $48 |
| Bsn Medical Inc | 1 | $30 |
| Convatec Inc. | 1 | $24 |
| AbbVie | 1 | $21 |
| Davol Inc. | 1 | $20 |
| KCI USA, Inc. | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Puraply Antimicrobial$7,229
- PuraPly$3,713
- NuShield$1,890
- PURAPLY WOUND MATRIX$1,840
- Affinity$1,690
- Apligraf$797
- NOVACHOR$690
- COLLAGENASE SANTYL$115
How this compares
$17,250 in reported general payments places this provider in the 95th percentile of 2,026 family providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 32 | $14,926 |
| Gentamicin Sulfate | 41 | $2,078 |
| Permethrin | 17 | $1,043 |
| Linezolid | 23 | $1,027 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 42 | $381 |
| Nystatin | 20 | $380 |
| Triamcinolone Acetonide | 21 | $326 |
| Doxycycline Hyclate | 32 | $225 |
| Gabapentin | 20 | $209 |
| Ciprofloxacin Hcl | 31 | $204 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 22 | $200 |
| Levofloxacin | 28 | $124 |
| Cephalexin | 22 | $114 |
| Mupirocin | 13 | $93 |
| Tramadol Hcl | 39 | $85 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $591 | $14,92632 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,026 family providers in Oklahoma.
Other family in Stillwater
- April WilcoxOklahoma City$245K
- Jeremy MorganOklahoma City$63K
- Samantha BellingerOklahoma City$39K
- Candy WilliamsTulsa$22K
- Lacey HillOklahoma City$20K
- Amanda OblanderYukon$17K
- Julia John SamuelOklahoma City$17K
- Jillian OakleafTulsa$15K
- Kristina SnyderOklahoma City$15K
- Lee MatlockTulsa$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.